Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nan Du
Institution:
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Zhongshan Hospital
ORCID:
0000-0001-8881-2625
Observed ORCID:
0000-0001-8881-2625
OpenAlex ID:
A5000717544
The Efficacy and Safety of Transcatheter Arterial Embolization to Treat Renal Hemorrhage after Percutaneous Nephrolithotomy
2019
·
Nan Du
, Jing-Qin Ma
, et al.
·
BioMed Research International
·
38
PDF
Hyaluronic Acid Modified Au@SiO2@Au Nanoparticles for Photothermal Therapy of Genitourinary Tumors
2022
·
Ruizhi Wang
, Nan Du
, et al.
·
Polymers
·
18
PDF
Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access
2019
·
Nan Du
, Min-Jie Yang
, et al.
·
Translational Cancer Research
·
15
PDF
Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments
2023
·
Wen Zhang
, Nan Du
, et al.
·
Discover Oncology
·
8
PDF
Pneumothorax and pulmonary hemorrhage after C-arm cone-beam computed tomography-guided percutaneous transthoracic lung biopsy: incidence, clinical significance, and correlation
2024
·
Yanjie Yang
, Jingqin Ma
, et al.
·
BMC Pulmonary Medicine
·
7
PDF
Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study
2021
·
Nan Du
, Jingqin Ma
, et al.
·
Journal of Clinical and Translational Hepatology
·
2
PDF
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
2020
·
Nan Du
, Jingqin Ma
, et al.
·
Journal of Visualized Experiments
·
2
Safety, efficacy, and pharmacokinetics of XNW28012, a tissue factor antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor (TOP1i) payload, in patients with advanced solid tumors: Results from a phase I/II study.
2026
·
Miaoyan Wei
, Si Shi
, et al.
·
Journal of Clinical Oncology
Tumor Volume Evaluation is a Superior Predictor of Prognosis Compared to RECIST in Metastatic Pancreatic Ductal Adenocarcinoma Undergoing Immunochemotherapy
2025
·
Dingxia Liu
, Nan Du
, et al.
·
Research Square
PDF
TQB2868 combined with anlotinib and nab-paclitaxel plus gemcitabine as first-line treatment for metastatic pancreatic cancer: A prospective, multicenter, single-arm, phase 2 study.
2025
·
Si Shi
, Xianjun Yu
, et al.
·
Journal of Clinical Oncology
PDF
One-day examination of triple nuclear medicine imaging and application in evaluating transarterial embolization
2024
·
Nan Du
, Guorong Jia
, et al.
·
Heliyon
Show more works
View as search
Works count:
11
Citation count:
90
H-index:
5
I10-index:
3
Year
Topic
Type